Scott Wisotsky, MD
Hand Surgery · Clearwater, FLNPI 1316961451
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,385 of the $23,610 with a category attached, or 73.6%. Medical Device Business Services, Inc. accounts for 74.1% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $9,503 and has fallen 93.4% since, to $628 in 2025.
Across 138 payments — averaging $171.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$17K
- Arthrex$2K
- Stryker$1K
- Zimmer Biomet$1K
- Endo Pharmaceuticals Inc.$371
- Coastal Medical Technologies LLC$293
- plus $2K from 25 others
What the payments were for
- Consulting fees$17,38574%
- Travel & lodging$2931%
- Food & beverage$4,58119%
- Education$1,3506%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 10 | $17,493 |
| Arthrex | 3 | $1,619 |
| Stryker | 13 | $1,180 |
| Zimmer Biomet | 16 | $1,060 |
| Endo Pharmaceuticals Inc. | 20 | $371 |
| Coastal Medical Technologies LLC | 9 | $293 |
| Amgen(2 entities) | 5 | $150 |
| Avita Medical Americas, LLC | 2 | $148 |
| Endo USA, Inc. | 6 | $134 |
| Encore Medical, LP | 3 | $130 |
| MVP Orthopedics Inc | 5 | $122 |
| Zyla Life Sciences, Inc. | 5 | $86 |
| Johnson & Johnson | 3 | $82 |
| Acumed LLC | 4 | $82 |
| Integra Lifesciences Corporation | 3 | $80 |
| Electronic Waveform Lab, Inc. | 6 | $65 |
| Orthofix Medical, Inc. | 4 | $59 |
| Smith+Nephew | 2 | $51 |
| Axogen | 2 | $48 |
| FX Shoulder Solutions, Inc | 1 | $43 |
| Bioventus LLC | 2 | $38 |
| Sonex Health, Inc. | 2 | $37 |
| ERMI LLC | 2 | $37 |
| Vertex | 1 | $31 |
| Anika Therapeutics, Inc. | 1 | $30 |
| Arthrosurface Incorporated | 2 | $30 |
| Dynasplint Systems Inc. | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 2 | $26 |
| Linvatec Corporation | 1 | $23 |
| Vericel Corporation | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GLOBAL$17,385
- DELTA$8,775
- AEQUALIS FLEX REVIVE$619
- Comprehensive Shoulder System$377
- MAKO$175
- AEQUALIS PERFORM REVERSED$160
- AEQUALIS PERFORM$160
- LATITUDE EV$160
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$160
- Comprehensive Anatomic$135
- TRIATHLON$120
- RECELL$117
- PERMEADERM$117
- Cohealyx$117
- mymobility Platform$105
How this compares
$23,610 in reported general payments places this provider in the 85th percentile of 173 hand surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiaflexCollagenase Clostridium Hist. | 20 | $177,363 |
| Celecoxib | 42 | $1,175 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 45 | $492 |
| Methylprednisolone | 32 | $264 |
| Mupirocin | 24 | $162 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $149 |
| Cephalexin | 16 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Endo Pharmaceuticals Inc.Xiaflex | $371 | $177,36320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 173 hand surgery providers in Florida.
Other hand surgery in Clearwater
- Jorge Orbay-CerratoMiami$12.5M
- Peter EvansStuart$525K
- Nirav GuptaOcala$491K
- Francisco RubioMiami$345K
- Justin ZumstegOrlando$133K
- Maria-Carolina Orbay AranMiami$108K
- Paul PatersonVero Beach$104K
- Helen Hui-ChouMiami$95K
- Philipp StreubelWeston$81K
- Roy CardosoCoral Gables$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.